Let’s start up with the current stock price of Viking Therapeutics Inc. (VKTX), which is $10.94 to be very precise. The Stock rose vividly during the last session to $11.04 after opening rate of $10.59 while the lowest price it went was recorded $10.30 before closing at $10.68.Recently in News on March 7, 2023, Viking Therapeutics to Participate at Upcoming Investor Conferences. Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will participate at two upcoming investor conferences. You can read further details here
Viking Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $11.98 on 03/03/23, with the lowest value was $2.02 for the same time period, recorded on 06/16/22.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Viking Therapeutics Inc. (VKTX) full year performance was 261.06%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Viking Therapeutics Inc. shares are logging -8.72% during the 52-week period from high price, and 441.58% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.02 and $11.98.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2109600 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Viking Therapeutics Inc. (VKTX) recorded performance in the market was 16.38%, having the revenues showcasing 200.55% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 911.74M, as it employees total of 21 workers.
Viking Therapeutics Inc. (VKTX) in the eye of market guru’s
During the last month, 9 analysts gave the Viking Therapeutics Inc. a BUY rating, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.42, with a change in the price was noted +7.19. In a similar fashion, Viking Therapeutics Inc. posted a movement of +191.73% for the period of last 100 days, recording 2,830,549 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for VKTX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Viking Therapeutics Inc. (VKTX): Stocks Technical analysis and Trends
Raw Stochastic average of Viking Therapeutics Inc. in the period of last 50 days is set at 73.58%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 43.97%. In the last 20 days, the company’s Stochastic %K was 38.61% and its Stochastic %D was recorded 30.96%.
If we look into the earlier routines of Viking Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 16.38%. Additionally, trading for the stock in the period of the last six months notably improved by 240.81%, alongside a boost of 261.06% for the period of the last 12 months. The shares increased approximately by -0.55% in the 7-day charts and went down by 1.58% in the period of the last 30 days. Common stock shares were driven by 200.55% during last recorded quarter.
